High Tide Inc. (HITI) Stock Price & Analysis

High Tide Inc. (HITI) closed at USD 2.56 on Thursday, October 15, 2026, down 0.78% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 2.58; the Oct 15, 2026 session ranged USD 2.55–2.65 on volume of 463,217 shares. Market capitalization is $228.21M, with a 52-week range of USD 2.02–3.5 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.

Also available as compact Markdown for AI agents: nexqual.com/HITI.md

Key facts (HITI)

Analysts (HITI)

Consensus Buy (mean 1.86 on a 1–5 scale), 7 analysts; mean target USD 4.67 (low 4, high 5).

Total return (dividends reinvested) (HITI)

1Y (from 2025-10-16)5Y (from 2021-10-11)
Total return-25.6%-54.7%
S&P 500 (SPY)+18.1%+85.1%
Per year-25.7%-14.6%
Volatility (annualized)43.0%65.2%
Max drawdown-40.4% (Oct 2025→Jul 2026)-85.9% (Nov 2021→Mar 2023)

Key Statistics (as of October 16, 2026 at 05:21 UTC)

PriceUSD 2.56
Change▼ 0.78% (down)
Previous CloseUSD 2.58
OpenUSD 2.56
Day RangeUSD 2.55 – 2.65
52-Week RangeUSD 2.02 – 3.5
Volume463,217 shares
Market Cap$228.21M
ExchangeNCM

Technical Analysis (HITI)

Nexqual's technical model rates HITI "NEUTRAL" based on 3 bullish and 3 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.

Overall SignalNEUTRAL
RSI (14)44.88 (neutral)
vs SMA50Above (USD 2.56)
MACD0 (positive)

Analyst Ratings (HITI)

Wall Street analysts rate HITI "Buy" based on 7 analysts, with a mean price target of USD 4.67 (range USD 4–5), per Nexqual as of October 16, 2026 at 05:21 UTC.

Consensus RatingBuy
Analyst Count7
Mean TargetUSD 4.67
High TargetUSD 5
Low TargetUSD 4
Buy / Hold / Sell7 / 0 / 0

Earnings (HITI)

Next Earnings Date2026-09-14
EPS EstimateUSD 0.03
Revenue Estimate$202.43M

Recent Earnings History

QuarterActual vs Estimate
2026-07-31USD 0.02 vs est 0.02 ▼ miss
2026-04-30USD 0 vs est -0.02 ▲ beat
2026-01-31USD 0.01 vs est 0 ▲ beat
2025-10-31USD -0.41 vs est 0.01 ▼ miss

Source: Nexqual, October 16, 2026 at 05:21 UTC.

Financials & Fundamentals (HITI)

Total Revenue$720.47M
Revenue Growth (latest quarter, YoY)+32.80%
Gross Margin+26.10%
Operating Margin+5.32%
Profit Margin-4.63%
ROE-26.04%
Debt / Equity1.03
Current Ratio1.5
Total Cash$38.09M
Total Debt$123.47M

Source: Nexqual, October 16, 2026 at 05:21 UTC.

Financial Health Score (HITI)

Nexqual rates High Tide Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.

GrowthSolid — Revenue +14% YoY (annual)
ProfitabilitySolid — Gross margin 26%, operating 5%
Balance SheetMixed — CAD 38M cash vs CAD 123M debt
Cash FlowSolid — Operating cash flow CAD 25M (TTM)
EfficiencyCritical — ROE -26%, ROA 5.7%

Ownership (HITI)

Insider Ownership+12.17%
Institutional Ownership+8.86%
Shares Outstanding89.14M
Float78.04M

Source: Nexqual, October 16, 2026 at 05:21 UTC.

Leadership (HITI)

High Tide Inc. is led by Harkirat Grover (age 43), Founder, CEO, President & Executive Chairman, per Nexqual as of October 16, 2026 at 05:21 UTC.

Founder, CEO, President & Executive ChairmanHarkirat Grover (age 43)
Chief Financial OfficerMayank Mahajan C.A. (age 38)
Chief Operating OfficerAman Sood
Chief Marketing OfficerAndreas-Alexander Palalas (age 34)
Senior Vice President of Legal & ComplianceJoy Lisa Avzar

Major Backers & Investors (HITI)

Notable institutional backers of High Tide Inc. include Tidal Investments LLC, Amplify ETF Trust-Amplify Alternative Harvest ETF, AdvisorShares Investments, LLC, according to Nexqual as of October 16, 2026 at 05:21 UTC.

Active Investors

InvestorStake
Tidal Investments LLC1.87%
Amplify ETF Trust-Amplify Alternative Harvest ETF1.87%
AdvisorShares Investments, LLC1.32%
Renaissance Technologies1.01%
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF1%
Two Sigma Investments, LP0.73%
Federation Des Caisses Desjardins Du Quebec0.29%
Baader Bank Aktiengesellschaft0.28%

Source: Nexqual, October 16, 2026 at 05:21 UTC.

Peers & Related Stocks

SymbolNamePriceChange
HUMHumana Inc.USD 432.2▲ 2.81%
BDXBecton, Dickinson and CompanyUSD 193.76▲ 3.41%
ARGXargenx SEUSD 846.27▲ 5.44%
NTRANatera, Inc.USD 404.79▲ 2.31%
CAHCardinal Health, Inc.USD 253.71▲ 5.84%
TAKTakeda Pharmaceutical Company LUSD 19.45▲ 5.02%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt